<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-pharmaceutics-10-00257" class="ref">
 <label class="label">25.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Zatta</surname>
    <given-names class="given-names">K.C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Frank</surname>
    <given-names class="given-names">L.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Reolon</surname>
    <given-names class="given-names">L.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Amaral-Machado</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Egito</surname>
    <given-names class="given-names">E.S.T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Gremi√£o</surname>
    <given-names class="given-names">M.P.D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pohlmann</surname>
    <given-names class="given-names">A.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Guterres</surname>
    <given-names class="given-names">S.S.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">An inhalable powder formulation based on micro-and nanoparticles containing 5-fluorouracil for the treatment of metastatic melanoma</article-title>
  <source class="source">Nanomaterials</source>
  <year class="year">2018</year>
  <volume class="volume">8</volume>
  <elocation-id class="elocation-id">75</elocation-id>
  <pub-id pub-id-type="doi" class="pub-id">10.3390/nano8020075</pub-id>
  <?supplied-pmid 29385692?>
  <pub-id pub-id-type="pmid" class="pub-id">29385692</pub-id>
 </element-citation>
</ref>
